3.61

1.12% 0.04

Tilray Brands Inc (TLRY)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TLRY? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$3.57

Offen:

$3.61

24-Stunden-Volumen:

4.08M

Relative Volume:

1.01

Marktkapitalisierung:

$506.93M

Einnahmen:

$858.28M

Nettoeinkommen (Verlust:

$-1.34B

KGV:

-0.2643

EPS:

-13.6608

Netto-Cashflow:

$-75.96M

1W Leistung:

-12.59%

1M Leistung:

-20.13%

6M Leistung:

-44.89%

1J Leistung:

-77.58%

1-Tages-Spanne:

$3.55

$3.65

1-Wochen-Bereich:

$3.54

$4.0999

52-Wochen-Spanne:

$3.54

$23.20

Tilray Brands Inc Stock (TLRY) Company Profile

Firmenname

Tilray Brands Inc

Sektor

Healthcare (1064)

Branche

Drug Manufacturers - Specialty & Generic (87)

Telefon

519.322.8800

Adresse

655 MADISON AVENUE, NEW YORK

Mitarbeiter

2,842

Twitter

@tilray

Nächster Verdiensttermin

2026-10-08

Neueste SEC-Einreichungen

TLRY's Discussions on Twitter

Compare TLRY vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TLRY Tilray Brands Inc	3.61	579.95M	858.28M	-1.34B	-75.96M	-13.66
TAK Takeda Pharmaceutical Co Adr	17.86	60.23B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	39.53	45.71B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	8.80	40.72B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	69.69	29.36B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	541.70	20.39B	3.17B	1.29B	1.01B	27.09

Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-02	Hochstufung	Roth Capital	Neutral → Buy
2026-01-27	Eingeleitet	Canaccord Genuity	Hold
2024-04-05	Bestätigt	Alliance Global Partners	Neutral
2022-11-02	Eingeleitet	Bernstein	Mkt Perform
2022-07-29	Herabstufung	The Benchmark Company	Hold → Sell
2022-03-04	Hochstufung	Canaccord Genuity	Hold → Buy
2021-11-18	Eingeleitet	Barclays	Underweight
2021-11-01	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2021-06-11	Herabstufung	CIBC	Sector Outperform → Neutral
2021-06-03	Hochstufung	Cantor Fitzgerald	Neutral → Overweight
2021-05-11	Fortgesetzt	Cowen	Outperform
2021-05-07	Fortgesetzt	Jefferies	Buy
2021-05-06	Eingeleitet	Canaccord Genuity	Buy
2021-04-28	Fortgesetzt	BofA Securities	Buy
2021-02-18	Herabstufung	Piper Sandler	Overweight → Neutral
2021-02-18	Herabstufung	The Benchmark Company	Buy → Hold
2020-11-16	Herabstufung	Jefferies	Hold → Underperform
2020-11-11	Herabstufung	Stifel	Hold → Sell
2020-10-01	Bestätigt	MKM Partners	Neutral
2020-09-21	Hochstufung	Jefferies	Underperform → Hold
2020-05-12	Bestätigt	The Benchmark Company	Buy
2020-04-16	Herabstufung	Jefferies	Hold → Underperform
2020-04-09	Herabstufung	Consumer Edge Research	Overweight → Equal Weight
2020-02-24	Herabstufung	Cowen	Outperform → Market Perform
2020-01-13	Eingeleitet	BofA/Merrill	Neutral
2019-11-13	Bestätigt	The Benchmark Company	Buy
2019-11-05	Eingeleitet	Cantor Fitzgerald	Neutral
2019-10-22	Bestätigt	Piper Jaffray	Overweight
2019-09-20	Eingeleitet	MKM Partners	Neutral
2019-08-14	Bestätigt	The Benchmark Company	Buy
2019-07-17	Eingeleitet	Ladenburg Thalmann	Neutral
2019-06-28	Eingeleitet	Consumer Edge Research	Overweight
2019-06-06	Eingeleitet	Stifel	Hold
2019-06-05	Eingeleitet	Oppenheimer	Perform
2019-05-15	Hochstufung	BMO Capital Markets	Underperform → Market Perform
2019-05-13	Eingeleitet	Alliance Global Partners	Neutral

Alle ansehen

Tilray Brands Inc Aktie (TLRY) Neueste Nachrichten

Oct 01, 2026

How Is Tilray Brands (TSX:TLRY) Expanding Beyond Cannabis Markets? - Kalkine Media

Oct 01, 2026

Tilray Brands Inc (TSX:TLRY) Navigates Strategic Integration And Regulatory Evolution - Kalkine Media

Oct 01, 2026

Tilray Brands (NASDAQ:TLRY) Expands Medical Reach - Kalkine Media

Oct 01, 2026

Why Is Tilray Brands (NASDAQ:TLRY) Suddenly a Must-Watch Cannabis Stocks Stock Today? - Kalkine Media

Oct 01, 2026

VFF Stock Up 49% in Three Months: Is the Rally Sustainable? - Zacks Investment Research

Oct 01, 2026

TLRY Q1'26 Earnings: revenue estimate is 267.77M USD - TradingView

Oct 01, 2026

Tilray Brands (NASDAQ:TLRY) Downgraded by Zacks Research to Strong Sell - MarketBeat

Oct 01, 2026

Tilray Brands (TLRY) Set to Announce Earnings on Thursday - MarketBeat

Oct 01, 2026

Sep 30, 2026

Tilray Brands (NASDAQ:TLRY) Shares Down 5.1%What's Next? - MarketBeat

Sep 30, 2026

Tilray Brands (TSX:TLRY): Is BrewDog Driving Its Beverage Strategy? - Kalkine Media

Sep 30, 2026

Tilray Brands (NASDAQ:TLRY) Sets Earnings Date as Cannabis Reform Talk Revives in Washington - Kalkine Media

Sep 30, 2026

Is Tilray Brands (NASDAQ:TLRY) Rewriting the Cannabis Stocks Playbook Today? - Kalkine Media

Sep 30, 2026

A 5%-alcohol blackberry cocktail with low sugar joins 10 Barrel's lineup. - Stock Titan

Sep 30, 2026

Sep 29, 2026

Tilray Brands (NASDAQ:TLRY) Stays in Focus as Cannabis Reform Talk Revives - Kalkine Media

Sep 29, 2026

Sep 28, 2026

Tilray Brands Announces 2026 Annual Meeting and Proxy Statement Filing - Kalkine Media

Sep 28, 2026